The invention discloses a medicine composition for clinic treatment of tumor. The medicine composition is prepared from the following raw materials in parts by weight: 1 to 5 parts of phellinus igniarius, 1 to 10 parts of ganoderma lucidum, 0.5 to 3 parts of radix taxi chinensis, 1 to 5 parts of radix salviae miltiorrhizae, 0.2 to 2 parts of rhizoma curcumae, 0.5 to 6 parts of fructus crataegi, 5to 10 parts of poria cocos, 2 to 6 parts of radix ginseng, 3 to 5 parts of bighead atractylodes rhizome, 0.5 to 6 parts of radix notoginseng, 0.1 to 2 parts of fructus hordei germinati, 1 to 5 parts of spica prunellae, 1 to 5 parts of radix aristolochiae debilis, 0.2 to 1 part of jatamans valeriana rhizome, 1 to 3 parts of herba hedyotidis diffusae, 0.3 to 2 parts of turtle shell processed by vinegar, 0.5 to 3 parts of herba asari sagittarioides, 2 to 5 parts of white paeony root, 3 to 10 parts of liquorice roots, 0.3 to 3 parts of bufo gargarizans processed by vinegar, 0.2 to 3 parts of driedgecko, 0.3 to 6 parts of dried leeches, 0.3 to 7 parts of woodlouse processed by vinegar, 0.5 to 3 parts of processed chilopod, 0.1 to 1 part of processed semen strychni, 1 to 5 parts of honeysuckleflower, 2 to 6 parts of herba scutellariae barbatae, 1 to 5 parts of radix angelicae sinensis, 0.3 to 2 parts of frankincense, 0.3 to 5 parts of myrrh, 1 to 6 parts of herba hedyotis, 2 to 5 parts ofdried chilopod, 0.3 to 4 parts of glossy ganoderma, 0.2 to 3 parts of borneol, 0.2 to 6 parts of ternate buttercup root and 1 to 5 parts of herba dendrobii. The medicine composition has the advantagesthat the recipes are diversified; the raw materials are diversified; the growth of the tumor can be effectively inhibited; the medicine effect is obvious; the curative effect is good; the tumor diseases can be effectively treated.